| Active substance |
Levofloxacin |
| Also known as |
L-isomer of Ofloxacin |
| Blood pressure |
No direct effects on blood pressure |
| Chemical name |
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid |
| Dosage (medical) |
Typically 250 mg to 750 mg once daily, depending on the infection type and severity |
| Dosage (sports) |
Not applicable |
| Effects |
Effective against a broad range of gram-positive and gram-negative bacteria |
| Formula |
C18H20FN3O4 |
| Half-life |
Approximately 6 to 8 hours |
| Hepatotoxicity |
Rare, but potential for liver enzyme elevations |
| Lab Test |
Not specifically monitored via lab tests in standard clinical practice |
| Main action |
Antibacterial |
| Side effects |
Nausea, diarrhea, headache, dizziness, insomnia, and potential for tendon damage |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Strength |
500mg |
| Substance class |
Fluoroquinolone antibiotic |
| Trade name |
Levaquin, Tavanic, and others |
| Use in sports |
Not typically used in sports, misuse can lead to serious health risks |
| Water Retention |
No significant effect on water retention |
| Manufacturer |
Cipla Ltd. |
| Packing |
10 tabs/blister |
